Aventis Pasteur Limited/Aventis Pasteur Limiteee
Records under this name other than patents Aventis Pasteur Limited/Aventis Pasteur Limiteee holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Aventis Pasteur Limited/Aventis Pasteur Limiteee
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,293,249 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Term ended Term ended Apr 13, 2019 · Medium confidence | Term ended | Term ended Apr 13, 2019 | Medium confidence |
| US 8,298,788 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Term ended Term ended Apr 10, 2019 · Medium confidence | Term ended | Term ended Apr 10, 2019 | Medium confidence |
| US 6,368,589 | Use of autologous promoters to express gene products in Bordetella Term ended Ended no later than Apr 9, 2019 · USPTO record | Term ended | Ended no later than Apr 9, 2019 | USPTO record |
| US 6,291,227 | Nucleic acids containing modified human immunodeficiency virus genomes devoid of long terminal repeats encoding non-infectious, replication-deficient, immunogenic retrovirus-like particles Term ended Term ended Sep 18, 2018 · USPTO record | Term ended | Term ended Sep 18, 2018 | USPTO record |
| US 7,122,368 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Term ended Term ended Jun 30, 2018 · Medium confidence | Term ended | Term ended Jun 30, 2018 | Medium confidence |
| US 8,609,107 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Term ended Term ended Jun 30, 2018 · Medium confidence | Term ended | Term ended Jun 30, 2018 | Medium confidence |
| US 6,264,954 | Haemophilus outer membrane protein Term ended Term ended Oct 1, 2017 · USPTO record | Term ended | Term ended Oct 1, 2017 | USPTO record |
| US 6,872,814 | Chlamydia antigens and corresponding DNA fragments and uses thereof Lapsed on the fee record Ended Mar 29, 2017 · USPTO record | Lapsed on the fee record | Ended Mar 29, 2017 | USPTO record |
| US 7,442,523 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Lapsed on the fee record Ended Oct 28, 2016 · Medium confidence | Lapsed on the fee record | Ended Oct 28, 2016 | Medium confidence |
| US 8,293,884 | Nucleic Acid and Amino Acid Sequences Relating to Streptococcus Pneumoniae for Diagnostics and Therapeutics Formerly held Lapsed on the fee record Ended Oct 23, 2016 · Medium confidence | Lapsed on the fee record | Ended Oct 23, 2016 | Medium confidence |